Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

40.65
Delayed Data
As of Aug 24
 -1.31 / -3.12%
Today’s Change
21.19
Today|||52-Week Range
60.79
-24.43%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close41.96
Today’s open41.81
Day’s range40.14 - 42.83
Volume611,116
Average volume (3 months)422,794
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-8.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.25+2.21%
PRTAProthena Corporation...-4.17-7.70%
IPXLImpax Laboratories I...-0.08-0.34%
ALDRAlder Biopharmaceuti...-2.27-6.81%
Data as of 4:01pm ET, 08/24/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs